Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
IHH Healthcare’s stock is trading near its recent highs. Short-term movement looks neutral to slightly positive, supported by hospital expansion and steady demand, but rising costs and ongoing legal cases may limit upside. Key resistance is around MYR 7.50.
IGB Berhad trades around RM3.20–3.30, near its 52-week high. Revenue is steady but profit growth is limited after one-off gains last year. Dividend yield is moderate. Short-term, the stock looks range-bound between RM3.10–3.35, with limited upside unless fresh catalysts emerge.
United Plantations trades around RM22.5, near the lower half of its RM20–33 range. Earnings remain strong with high margins and steady dividends, but CPO price volatility is a key risk. Short-term, the stock looks sideways to mildly bullish, with support at RM21.8–22.0 and resistance near RM24.0.
Allianz Malaysia trades near RM18.3, within its RM16.5–21 range. Earnings and dividends are strong, but momentum looks weak. Short-term, the stock may consolidate with support around RM18.0 and resistance near RM19.5.
Southern Acids (M) Berhad trades near RM3.30, within its 52-week range of RM2.8–3.6. Earnings have improved strongly with a solid balance sheet, though oleochemical margins and CPO volatility remain risks. Short-term, the stock looks range-bound between RM3.2–3.4, with resistance at RM3.43 and support near RM3.16.
PJBumi Berhad trades near RM2.70, close to its 52-week high after a sharp rally. The company is still loss-making, and technical indicators show overbought conditions. Short-term, the stock may consolidate between RM2.5–2.8, with risk of a pullback if profit-taking intensifies, unless fresh catalysts push it above RM3.
Gamuda Berhad trades near RM 5.64, close to its 52-week high. Short term, it’s likely to consolidate around RM 5.55–5.65. Strong EPF support and a MYR 24.2b order book provide stability. Upcoming Q4 results and the October budget could drive it above RM 6.20, with analysts’ targets up to RM 7.80. Medium-term outlook is positive.